Sagimet Biosciences (SGMT) Interest & Investment Income (2022 - 2026)
Sagimet Biosciences (SGMT) posted quarterly Interest & Investment Income of -$112000.0 for Q1 2026, down 2.75% year-over-year from -$115169.8 in Q1 2025, and down 109.36% quarter-over-quarter from $1.2 million in Q4 2025.
Sagimet Biosciences (SGMT) Interest & Investment Income (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Interest & Investment Income history runs 5 years deep, the most recent figure standing at -$112000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 2.75% year-over-year to -$112000.0; the TTM figure through Mar 2026 stood at $2.5 million (up 6.34% YoY), while the FY2025 annual figure was $5.9 million, down 34.16% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$112000.0, down from $1.2 million in the prior quarter.
- The five-year high for Interest & Investment Income was $2.0 million in Q4 2024, with the low at -$1.4 million in Q4 2023.
- The 5-year median for Interest & Investment Income is $42000.0 (2023), against an average of $300875.0.
- Peak annual rise in Interest & Investment Income reached 402.29% in 2023, while the deepest fall reached 841.97% in 2023.
- Sagimet Biosciences' Interest & Investment Income stood at $193000.0 in 2022, then tumbled by 841.97% to -$1.4 million in 2023, then jumped by 239.25% to $2.0 million in 2024, then plunged by 39.97% to $1.2 million in 2025, then sank by 109.36% to -$112000.0 in 2026.
- Business Quant data shows SGMT's Interest & Investment Income at -$112000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Sagimet Biosciences | 649.79 Mn | 649.79 Mn | - | 1.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.87 Mn |
| Mar 31, 2026 | -112,000.00 |
| Dec 31, 2025 | 1.20 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | -45,000.00 |
| Mar 31, 2025 | -109,000.00 |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 464,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Mar 31, 2024 | -23,000.00 |
| Dec 31, 2023 | -1.43 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 71,000.00 |
| Dec 31, 2022 | 193,000.00 |
| Sep 30, 2022 | 218,000.00 |
| Jun 30, 2022 | -106,000.00 |